Cargando…
Synthesis and Optimization of the Labeling Procedure of (99m)Tc-Hynic-Interleukin-2 for In vivo Imaging of Activated T lymphocytes
INTRODUCTION: We have previously described the labeling of interleukin-2 (IL2) with (123)I and (99m)Tc-N(3)S. Both radiopharmaceuticals were successfully applied in humans to image several inflammatory lesions and autoimmune diseases characterized by tissue infiltrating lymphocytes expressing the IL...
Autores principales: | D’Alessandria, Calogero, di Gialleonardo, Valentina, Chianelli, Marco, Mather, Stephen J., de Vries, Erik F. J., Scopinaro, Francesco, Dierck, Rudi A., Signore, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946565/ https://www.ncbi.nlm.nih.gov/pubmed/19949980 http://dx.doi.org/10.1007/s11307-009-0285-1 |
Ejemplares similares
-
Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019) -
(99m)Tc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients
por: Malviya, G., et al.
Publicado: (2011) -
(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014) -
(99m)Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
por: Lambert, Bieke, et al.
Publicado: (2016) -
(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)